Patents
Patents for C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
08/2003
08/27/2003CN1119423C Process for ferment ative preparation of clavam derivatives wherehy the levels of ammonia and urea in the fermentation medium are kept low
08/20/2003CN1118469C Preparation of and/or purifing method for clavate acid or salt or ester acceptable in pharmacy
08/14/2003US20030153549 Clavulinic acid derivatives; antibiotics
07/2003
07/23/2003EP1328528A1 Pharmaceutical compositions
07/23/2003CN1115147C Improved method for preparing potassium clavulanate
07/16/2003EP1326608A1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
07/16/2003EP1326607A1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids
07/09/2003CN1429227A Process for purification of salt of clavulanic acid
07/09/2003CN1113885C Process for producing beta-lactam derivs.
07/03/2003US20030124690 Novel compounds
06/2003
06/26/2003WO2003052113A1 Cyclisation process for the preparation of c-2 beta-lactam compounds
06/18/2003EP1319086A1 Process for the preparation of clavulanic acid
05/2003
05/20/2003US6566106 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof
05/07/2003EP0821687B1 Preparation of clavulanate salts
04/2003
04/16/2003CN1105724C Chavulanic acid extracting process
03/2003
03/19/2003EP0711350B1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
02/2003
02/26/2003EP1284978A1 Process for the purification of a salt of clavulanic acid
02/26/2003EP0796340B1 Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
02/12/2003CN1101396C Isolation of claulanic acid from fermentation broth by ultrafiltration
01/2003
01/30/2003US20030022882 Forming the 2-amino-2,4,4-trimethylpentane salt of clavulanic acid and converting that salt into a pharmaceutically acceptable salt of clavulanic acid, such as potassium clavulanate
01/30/2003US20030022321 Novel compounds
11/2002
11/13/2002EP1255760A1 Clavams as protease inhibitors
09/2002
09/11/2002CN1090636C Production of salt clavulanic acid
09/04/2002EP1236729A1 Clavulanic acid aldehyde, beta-lactamase inhibitor
07/2002
07/09/2002US6417352 Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid
07/02/2002US6414142 Concurrently adding solution of potassium 2-ethyl hexanoate in isopropanol and solution of tertiary-butylamino clavulanate in aqueous isopropanol to mixture of isopropanol and acetone, precipitating potassium clavulanate as rosette-like starbursts
06/2002
06/13/2002US20020072513 Process for the production of clavulanic acid salts
05/2002
05/07/2002CA2215038C Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
04/2002
04/30/2002CA2226683C Isolation of clavulanic acid from fermentation broth by ultrafiltration
04/25/2002WO2002032906A1 Pharmaceutical compositions
04/25/2002WO2002032424A1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
04/25/2002WO2002032423A1 Pharmaceutical compositions containing oxapenem-3-carboxylic acids
04/24/2002EP1199077A1 Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
04/17/2002CN1345231A Agglomerates by crystallisation
04/09/2002US6369219 Preparation of clavulanate salts
03/2002
03/27/2002CN1081640C Diclavulanate salt of diamino ether and its preparing method
03/21/2002WO2002022846A1 Process
01/2002
01/30/2002EP0904284B1 6-substituted amino-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives as cysteine protease inhibitors
01/29/2002CA2092330C Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
01/02/2002EP1165049A2 Agglomerates by crystallisation
11/2001
11/22/2001WO2001087891A1 Process for the purification of a salt of clavulanic acid
11/01/2001US20010036940 Chemical intermediates
10/2001
10/31/2001CN1320166A Fermentation of clavulanic acid at a controlled level of ammonia
10/11/2001US20010029038 Purification of fermented clavulanic acid
10/09/2001US6300495 Process for the preparation of a metal salt of clavulanic acid
09/2001
09/27/2001US20010025104 Amination of clavulanic acid
09/12/2001EP0843680B1 Process for the preparation of potassium clavulanate
09/12/2001CN1312814A Improved process for preparing salts and esters of clavulanic acid
08/2001
08/15/2001CN1308682A Fermentation process to produce clavulanic acid at a low concentration of free amino acids
08/14/2001US6274575 Isolation of clavulanic acid from fermentation broth by ultrafiltration
08/02/2001WO2001055153A1 Clavams as protease inhibitors
07/2001
07/25/2001EP1117820A1 Fermentation of clavulanic acid at a controlled level of ammonia
07/12/2001US20010007761 Novel process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof
06/2001
06/20/2001EP0741732B1 Process for the preparation of a salt of clavulanic acid
05/2001
05/29/2001US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents
05/22/2001US6235506 Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
05/16/2001CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor
05/09/2001EP1097238A1 Fermentation process to produce clavulanic acid at a low concentration of free amino acids
05/02/2001EP1095046A1 Improved process for the preparation of salts and esters of clavulanic acid
05/02/2001CN1065246C Process for preparation of salt of clavulanic acid
04/2001
04/17/2001US6218380 Pharmaceutical compositions
04/11/2001CN1064364C Method for mfg clavulanic acid salts
04/04/2001EP1088826A1 Process for the preparation of potassium clavulanate
03/2001
03/27/2001US6207428 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of streptomyces sp. P 6621 FERM P 2804
02/2001
02/13/2001CA2001203C Novel antimicrobial dithiocarbamoyl quinolones
01/2001
01/30/2001US6180782 Preparation of clavulanate salts
01/09/2001US6172221 Clavulanic acid extraction process
12/2000
12/19/2000CA2001225C Antimicrobial lactam-quinolones
11/2000
11/02/2000WO2000041478A3 Agglomerates by crystallisation
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
10/2000
10/17/2000US6133441 Production of a salt of clavulanic acid
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/03/2000US6127358 Purification by membrane microfiltration, then ultrafiltration
09/2000
09/13/2000EP1034784A2 Pharmaceutical formulations containing clavulanic acid and an antibacterial agent
08/2000
08/23/2000CN1055694C Novel process for isolation of clavulanic acid and of pharmaceutically acceptable salts
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
07/2000
07/20/2000WO2000041478A2 Agglomerates by crystallisation
07/05/2000EP0680322B1 Use of clavulanate and an antibacterial compound for the treatment of infections
06/2000
06/28/2000CN1258298A Process for preparation of metal salt of clavulanic acid
06/28/2000CN1258297A Process for producing beta-lactam derivs.
05/2000
05/17/2000EP1000945A1 PROCESS FOR PRODUCING $g(b)-LACTAM DERIVATIVES
05/03/2000EP0997466A1 Novel antimicrobial lactam-quinolones
04/2000
04/26/2000EP0827504B1 Process for manufacturing clavulanic acid salt
04/26/2000CN1251612A Novel compound
04/18/2000US6051703 Broad spectrum antibiotic
04/11/2000US6048977 Clavulanic acid and salts thereof
04/06/2000WO2000018947A1 Fermentation of clavulanic acid at a controlled level of ammonia
04/06/2000CA2342181A1 Fermentation of clavulanic acid at a controlled level of ammonia
02/2000
02/29/2000US6031093 Solid salts of clavulanic acid
02/23/2000EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors
01/2000
01/27/2000WO2000004028A1 Improved process for the preparation of salts and esters of clavulanic acid
01/27/2000CA2337072A1 Improved process for the preparation of salts and esters of clavulanic acid
01/13/2000WO2000001840A1 Fermentation process to produce clavulanic acid at a low concentration of free amino acids
01/13/2000CA2336363A1 Fermentation process to produce clavulanic acid at a low concentration of free amino acids
01/12/2000EP0970198A2 Novel compounds
01/12/2000EP0970087A1 A process for the preparation of a metal salt of clavulanic acid
12/1999
12/15/1999CN1238776A Process for the preparation of salts and esters of clavulanic acid
12/07/1999US5998612 Antibiotic synthesis
11/1999
11/30/1999US5994534 Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
11/30/1999US5994342 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agents
1 2 3 4 5 6 7